Month: July 2021

TORONTO, July 08, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, announced today the opening of Liberty Health Sciences Key West, the Company’s 37th open dispensary in Florida. The dispensary is located at 826 Duval Street, Key West, Florida, 33040. The 1,500 sq. ft. location sits on the main strip of Downtown Key West, with a diverse selection of restaurants, shops and attractions nearby. The dispensary features a selection of flower products, in addition to the company’s newly launched Origyn concentrates and Big Pete’s Cookies. Jonathan Sandelman, CEO of Ayr, said, “We are continuing to execute on our Florida plan, opening dispensaries in prime locations while continually enhancing our cultivation efforts to make us the...

FREMONT, Calif., July 08, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will report financial results for its fiscal 2021 fourth quarter and full year ended May 31, 2021 on Thursday, July 15, 2021 following the close of the market. The Company will host a conference call and webcast at 5:00 p.m. Eastern time to discuss the results.What: Aehr Test Systems fourth quarter fiscal 2021 financial results conference call.   When: Thursday, July 15, at 5:00 p.m. Eastern Time (2:00 p.m. PT).   Dial in Number: To access the live call, dial 800-367-2403 (US and Canada) or +1 334-777-6978 (International) and give the participant passcode 9748167.   Webcast:  To access the live webcast, please visit the...

ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia CAMBRIDGE, Mass. and TOKYO, July 08, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced the U.S. Food and Drug Administration (FDA) has approved an updated label for ADUHELM™ (aducanumab-avwa) injection 100 mg/mL solution. The update includes an addition to the Indications and Usage section of the label (Section 1) to emphasize the disease stages studied in the clinical trials, as seen below (italics to note updated language). ADUHELM is indicated for the treatment of Alzheimer’s disease. Treatment with ADUHELM should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) — Hanstone Gold Corp. (TSXV: HANS) (FSE: HGO) (“Hanstone” or the “Company“), announces that it will conduct a non-brokered private placement for aggregate gross proceeds of up to $4,000,000 (the “Offering”), consisting of: (i) units of the Company (the “Units”) at a price of $0.40 per Unit, and (ii) flow-through units of the Company (the “FT Units”) at a price of $0.44 per FT Unit. Each Unit will be comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each FT Unit shall consist of one Common Share of the Company which will qualify as a “flow-through share” (within the meaning of the Income...

Picture 1Figure 1VANCOUVER, British Columbia and IRVINE, Calif., July 08, 2021 (GLOBE NEWSWIRE) — PowerTap Hydrogen Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) is pleased to announce that its wholly-owned subsidiary, PowerTap Hydrogen Fueling Corp. (“PowerTap Fueling”) has completed the engineering design of the PowerTap Gen3 making significant improvements in its steam methane reformer (SMR) that increases the production of hydrogen, reduces feedstock requirements, and extends the life of the SMR. The design of the SMR remains subject to revisions, pending the successful manufacturing of a prototype that achieves all of the functionalities as intended. The diagram below illustrates the current design of the SMR. Specific innovations include:The improvement...

WASHINGTON, July 08, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the second quarter ended June 30, 2021, before the New York market opens on Thursday, July 29, 2021. A conference call will be held to discuss these financial results on Thursday, July 29, 2021, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company’s investor relations website. A replay of the webcast will be available on the Company’s investor relations website for 90 days. About FTI ConsultingFTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political &...

Dallas, July 08, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end client experience platform for small businesses, today announced it has ranked on the Selling Power 50 Best Companies to Sell For 2021 list for the fifth consecutive year. Improving its ranking year over year, Thryv nabbed the 11th spot on this year’s list—which has been published for its 21st consecutive year. Each year, the corporate research team at Selling Power magazine assembles and publishes its list of the 50 Best Companies to Sell For. The list encompasses companies of all sizes, with sales forces ranging from fewer than 100 salespeople to companies with sales-force numbers in the thousands. Our primary goal at Thryv is to help small businesses succeed. That mission was more amplified this past year...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. FURTHER RESTRICTIONS ARE APPLICABLE, AS DESCRIBED IN THE ATTACHED BUY-BACK OFFER DOCUMENT. Reference is made to the stock exchange notification published by Electromagnetic Geoservices ASA (“EMGS” or the “Company”) on 7 July 2021 wherein the Company announced its intention to launch a voluntary, partial buy-back of bonds with an aggregate principal amount of up to USD 4,000,000 under the Company’s outstanding bond issue FRN Electromagnetic Geoservices ASA Senior Unsecured Convertible USD 32,500,000 Bonds 2018/2023. EMGS has today published the attached Buy-Back Offer...

BROOKFIELD, NEWS, July 08, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN) and Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) (collectively “Brookfield Infrastructure”) today announced they are initiating a voluntary sale program (the “Program”) through which eligible holders of BIP limited partnership units and/or BIPC class A exchangeable subordinate voting shares (collectively the “Odd Lot Securities”) may conveniently sell their Odd Lot Securities. The program benefits securityholders who held fewer than 100 Odd Lot Securities, as of July 7, 2021, being the record date in respect of the Program, and want to sell their Odd Lot Securities without paying brokerage commissions, thereby avoiding having to incur fees that could represent a material percentage of their proceeds....

TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger and Michael Rice to its Board of Directors, effective July 7, 2021. Professor Ruth Arnon has stepped down from her role as a member of VBL’s Board of Directors, effective July 6, 2021. She will continue her engagement with VBL as a scientific consultant and a member of its Scientific Advisory Board. “We are pleased to welcome Alison and Michael as the newest members of our Board of Directors,” said Bennett Shapiro, M.D., Chairman of VBL’s Board of Directors. “Alison’s extensive experience commercializing products globally at bluebird bio and Bristol-Myers Squibb and Michael’s expertise in healthcare capital markets will be invaluable to us as we approach disclosure of topline data from the OVAL clinical...